This section of the FEDERAL REGISTER

contains documents other than rules or

proposed rules that are applicable to the

public. Notices of hearings and investigations,

committee meetings, agency decisions and

rulings, delegations of authority, filing of

petitions and applications and agency

statements of organization and functions are

examples of documents appearing in this

section.

Notices Federal Register

7989 

Vol. 86, No. 21 

Wednesday, February 3, 2021 

1See Antidumping or Countervailing Duty Order, 

Finding, or Suspended Investigation; Opportunity 

to Request Administrative Review, 85 FR 39531 

(July 1, 2020). 

2See COFCO’s Letter, ‘‘Citric Acid and Certain 

Citrate Salts from Thailand: Request for 

Administrative Review,’’ dated July 28, 2020; see 

also Sunshine’s Letter, ‘‘Antidumping Duty 

Investigation of Citric Acid and Certain Citrate Salts 

from Thailand: Sunshine Biotech Request for 

Review,’’ dated July 31, 2020; and Petitioners’ 

Letter, ‘‘Citric Acid and Certain Citrate Salts From 

Thailand: Petitioners’ Request For Administrative 

Review,’’ dated July 30, 2020 (the petitioners 

requested review of COFCO, Sunshine, and Niran). 

3See Initiation of Antidumping and 

Countervailing Duty Administrative Reviews, 85 FR 

172 (September 3, 2020). 

4See Memorandum, ‘‘Antidumping Duty 

Administrative Review of Citric Acid and Certain 

Citrate Salts from Thailand; 2019–2020: Selection of 

Respondents for Individual Examination,’’ dated 

September 17, 2020. See also Antidumping 

Questionnaires sent to COFCO and Sunshine, dated 

September 21, 2020. 

5See Niran’s Letter, ‘‘Citric Acid and Certain 

Citrate Salts from Thailand: No Shipment 

Certification,’’ dated September 18, 2020. 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–04–2021] 

Foreign-Trade Zone (FTZ) 22— 

Chicago, Illinois, Notification of 

Proposed Production Activity, AbbVie, 

Inc. (Pharmaceutical Products), North 

Chicago and Lake County, Illinois 

AbbVie, Inc. (AbbVie) submitted a 

notification of proposed production 

activity to the FTZ Board for its 

facilities in North Chicago and Lake 

County, Illinois. The notification 

conforming to the requirements of the 

regulations of the FTZ Board (15 CFR 

400.22) was received on January 27, 

2021. 

AbbVie already has authority to 

produce pharmaceutical products 

within Subzone 22S. The current 

request would add a finished product 

and a foreign status material to the 

scope of authority. Pursuant to 15 CFR 

400.14(b), additional FTZ authority 

would be limited to the specific foreignstatus material and specific finished 

product described in the submitted 

notification (as described below) and 

subsequently authorized by the FTZ 

Board. 

Production under FTZ procedures 

could exempt AbbVie from customs 

duty payments on the foreign-status 

materials/components used in export 

production. On its domestic sales, for 

the foreign-status materials/components 

noted below and in the existing scope 

of authority, AbbVie would be able to 

choose the duty rates during customs 

entry procedures that applies to 

IMBRUVICA® tablets (duty-free). 

AbbVie would be able to avoid duty on 

foreign-status components which 

become scrap/waste. Customs duties 

also could possibly be deferred or 

reduced on foreign-status production 

equipment. 

The material sourced from abroad is 

Ibrutinib active pharmaceutical 

ingredient (duty rate 6.5%). The request 

indicates that Ibrutinib is subject to 

duties under Section 301 of the Trade 

Act of 1974 (Section 301), depending on 

the country of origin. The applicable 

Section 301 decisions require subject 

merchandise to be admitted to FTZs in 

privileged foreign status (19 CFR 

146.41). 

Public comment is invited from 

interested parties. Submissions shall be 

addressed to the Board’s Executive 

Secretary and sent to: ftz@trade.gov. The 

closing period for their receipt is March 

15, 2021. 

A copy of the notification will be 

available for public inspection in the 

‘‘Reading Room’’ section of the Board’s 

website, which is accessible via 

www.trade.gov/ftz. 

For further information, contact 

Christopher Wedderburn at 

Chris.Wedderburn@trade.gov. 

Dated: January 28, 2021. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2021–02234 Filed 2–2–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

[A–549–833] 

Citric Acid and Certain Citrate Salts 

From Thailand: Partial Rescission of 

Antidumping Duty Administrative 

Review, 2019–2020 

AGENCY: Enforcement and Compliance, 

International Trade Administration, 

Department of Commerce. 

SUMMARY: The Department of Commerce 

(Commerce) is rescinding the 

administrative review of the 

antidumping duty order on citric acid 

and certain citrate salts (citric acid) from 

Thailand covering the period of review 

(POR) July 1, 2019, through June 30, 

2020, in part, with respect to Niran 

(Thailand) Co., Ltd. (Niran), based on a 

timely withdrawal of the request for 

review for Niran. 

DATES: Applicable February 3, 2021. 

FOR FURTHER INFORMATION CONTACT: Joy 

Zhang, AD/CVD Operations, Office III, 

Enforcement and Compliance, 

International Trade Administration, 

U.S. Department of Commerce, 1401 

Constitution Avenue NW, Washington, 

DC 20230; telephone: (202) 482–1168. 

SUPPLEMENTARY INFORMATION: 

Background 

On July 1, 2020, Commerce published 

in the Federal Register a notice of 

opportunity to request an administrative 

review of the antidumping duty order 

on citric acid from Thailand for the 

period July 1, 2019, through June 30, 

2020.1 Based on timely requests from 

COFCO Biochemical (Thailand) Co., 

Ltd. (COFCO), Sunshine Biotech 

International Co., Ltd. (Sunshine), and 

Archer Daniels Midland Company, 

Cargill, Incorporated, and Tate & Lyle 

Ingredients Americas LLC, domestic 

producers of the subject merchandise 

and petitioners in the original 

investigation (collectively, the 

petitioners),2 on September 3, 2020, in 

accordance with 751(a)(1) of the Tariff 

Act of 1930, as amended (the Act), 

Commerce published in the Federal 

Register a notice of initiation of 

administrative review covering COFCO, 

Sunshine, and Niran.3 On September 

17, 2020, Commerce selected COFCO 

and Sunshine for individual 

examination and issued the 

antidumping duty questionnaire to the 

companies.4

On September 18, 2020, Niran filed a 

no-shipment certification.5 On October 

8, 2020, U.S. Customs and Border 

Protection (CBP) confirmed that there 

were no shipments of subject 

merchandise from Niran during the 


jbell on DSKJLSW7X2PROD with NOTICES
7990 Federal Register / Vol. 86, No. 21 / Wednesday, February 3, 2021 / Notices 

6See Memorandum, ‘‘Citric Acid and Certain 

Citrate Salts from Thailand (A–549–833): No 

shipments inquiry with respect to the company 

listed below during the period 7/1/2019 through 6/ 

30/2020,’’ dated October 9, 2020. 

7See Petitioners’ Letter, ‘‘Citric Acid and Certain 

Citrate Salts From Thailand: Partial Withdrawal of 

Request For Administrative Review,’’ dated 

November 19, 2020. 

8See, e.g., Certain Lined Paper Products from 

India: Notice of Partial Rescission of Antidumping 

Duty Administrative Review and Extension of Time 

Limit for the Preliminary Results of Antidumping 

Duty Administrative Review, 74 FR 21781 (May 11, 

2009); see also Carbon Steel Butt-Weld Pipe Fittings 

from Thailand: Rescission of Antidumping Duty 

Administrative Review, 74 FR 7218 (February 13, 

2009). 

POR.6 On November 19, 2020, the 

petitioners withdrew their request for an 

administrative review with respect to 

Niran.7

Scope of the Order 

The merchandise covered by the order 

is citric acid and certain citrate salts 

from Thailand. The scope of the order 

includes all grades and granulation sizes 

of citric acid, sodium citrate, and 

potassium citrate in their unblended 

forms, whether dry or in solution, and 

regardless of packaging type. The scope 

also includes blends of citric acid, 

sodium citrate, and potassium citrate; as 

well as blends with other ingredients, 

such as sugar, where the unblended 

form(s) of citric acid, sodium citrate, 

and potassium citrate constitute 40 

percent or more, by weight, of the blend. 

The scope also includes all forms of 

crude calcium citrate, including 

dicalcium citrate monohydrate, and 

tricalcium citrate tetrahydrate, which 

are intermediate products in the 

production of citric acid, sodium citrate, 

and potassium citrate. 

The scope includes the hydrous and 

anhydrous forms of citric acid, the 

dihydrate and anhydrous forms of 

sodium citrate, otherwise known as 

citric acid sodium salt, and the 

monohydrate and monopotassium forms 

of potassium citrate. Sodium citrate also 

includes both trisodium citrate and 

monosodium citrate which are also 

known as citric acid trisodium salt and 

citric acid monosodium salt, 

respectively. 

The scope does not include calcium 

citrate that satisfies the standards set 

forth in the United States Pharmacopeia 

and has been mixed with a functional 

excipient, such as dextrose or starch, 

where the excipient constitutes at least 

2 percent, by weight, of the product. 

Citric acid and sodium citrate are 

classifiable under 2918.14.0000 and 

2918.15.1000 of the Harmonized Tariff 

Schedule of the United States (HTSUS), 

respectively. Potassium citrate and 

crude calcium citrate are classifiable 

under 2918.15.5000 and, if included in 

a mixture or blend, 3824.99.9295 of the 

HTSUS. Blends that include citric acid, 

sodium citrate, and potassium citrate 

are classifiable under 3824.99.9295 of 

the HTSUS. Although the HTSUS 

subheadings are provided for 

convenience and customs purposes, the 

written description of the merchandise 

is dispositive. 

Partial Rescission of Administrative 

Review 

Pursuant to 19 CFR 351.213(d)(1), 

Commerce will rescind an 

administrative review, in whole or in 

part, if a party who requested the review 

withdraws the request within 90 days of 

the date of publication of notice of 

initiation of the requested review. The 

aforementioned withdrawal request was 

timely submitted, and no other 

interested party requested an 

administrative review of this particular 

company. Therefore, in accordance with 

19 CFR 351.213(d)(1), and consistent 

with our practice,8 we are rescinding 

this review of the antidumping duty 

order on citric acid from Thailand, in 

part, with respect to Niran. 

The review will continue with respect 

to COFCO and Sunshine. 

Assessment 

Commerce will instruct CBP to assess 

antidumping duties on all appropriate 

entries. For Niran, for which this review 

is rescinded, antidumping duties shall 

be assessed at rates equal to the cash 

deposit of estimated antidumping duties 

required at the time of entry, or 

withdrawal from warehouse, for 

consumption, during the period July 1, 

2019, through June 30, 2020, in 

accordance with 19 CFR 

351.212(c)(1)(i). Commerce intends to 

issue appropriate assessment 

instructions to CBP no earlier than 35 

days after the date of publication of this 

rescission notice in the Federal 

Register. 

Notification to Importers 

This notice serves as a reminder to 

importers of their responsibility under 

19 CFR 351.402(f)(2) to file a certificate 

regarding the reimbursement of 

antidumping duties prior to liquidation 

of the relevant entries during this 

review period. Failure to comply with 

this requirement could result in 

Commerce’s presumption that 

reimbursement of antidumping duties 

occurred and the subsequent assessment 

of doubled antidumping duties. 

Notification Regarding Administrative 

Protective Order 

This notice serves as a final reminder 

to parties subject to administrative 

protective order (APO) of their 

responsibility concerning the 

disposition of proprietary information 

disclosed under an APO in accordance 

with 19 CFR 351.305(a)(3), which 

continues to govern business 

proprietary information in this segment 

of the proceeding. Timely written 

notification of the return/destruction of 

APO materials or conversion to judicial 

protective order is hereby requested. 

Failure to comply with the regulations 

and terms of an APO is a violation 

which is subject to sanction. 

Notification to Interested Parties 

This notice is issued and published in 

accordance with sections 751(a)(1) and 

777(i)(1) of the Act, and 19 CFR 

351.213(d)(4). 

Dated: January 29, 2021. 

James Maeder, 

Deputy Assistant Secretary for Antidumping 

and Countervailing Duty Operations. 

[FR Doc. 2021–02232 Filed 2–2–21; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

[C–489–843] 

Prestressed Concrete Steel Wire 

Strand From the Republic of Turkey: 

Countervailing Duty Order 

AGENCY: Enforcement and Compliance, 

International Trade Administration, 

Department of Commerce 

SUMMARY: Based on affirmative final 

determinations by the Department of 

Commerce (Commerce) and the 

International Trade Commission (ITC), 

Commerce is issuing a countervailing 

duty order on prestressed concrete steel 

wire strand (PC strand) from the 

Republic of Turkey (Turkey). 

DATES: Applicable February 3, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Jacob Garten at (202) 482–3342, AD/ 

CVD Operations, Enforcement and 

Compliance, U.S. Department of 

Commerce, 1401 Constitution Avenue 

NW, Washington, DC 20230. 

SUPPLEMENTARY INFORMATION: 

Background 

On December 11, 2020, Commerce 

published its affirmative final 

determination in the countervailing 

duty investigation of PC Strand from 


jbell on DSKJLSW7X2PROD with NOTICES